See also this year's filing and all EDGAR filings for this company.
PDF Report 0001549595_2021_Nurix_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001549595, Nurix Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 298,434,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 6,672,000 |
| 3 | remainder_Assets | 91,237,000 |
| 4 | LiabilitiesCurrent | 44,539,000 |
| 5 | LiabilitiesNoncurrent | 61,535,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,309,000 |
| 9 | ResearchAndDevelopmentExpense | 66,494,000 |
| 10 | remainder_Expenses | -20,535,000 |
| 11 | remainder_Revenues | 19,026,000 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | 89,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 396,343,000 |
| 1 | Liabilities | 106,074,000 |
| 2 | Expenses | 62,268,000 |
| 3 | Revenues | 19,026,000 |
| 4 | StockholdersEquity | 290,269,000 |
| 5 | NetIncome | -43,242,000 |
| 6 | ComprehensiveNetIncome | -43,197,500 |
| 7 | BaseVar | 291,900,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.35 |
| 9 | EconomicCapitalRatio | 3.25 |
Edgar->Model Mapping
Feature Distribution
